Tracking SUPN? Get live short interest, options flow, and signals on ORTEX.Sign up free →
SU
Supernus, Inc. (SUPN) short interest & options flow
NASDAQSupernus Pharmaceuticals has collapsed 22% in a single session, leaving the stock down 19% on the week and 21% over the past month, the kind of move that reorders every positioning story in the register. The price action is the story. The October 29 earnings release for the Indivior acquisition deal produced a 1.7% one-day move, but the real shock came on November 3, when the stock…
$26.16-2.17% 1d-26.04% 1w-27.13% 1mClose: 6 Nov 2026
- Market cap
- $5.43B
- Next earnings
- 25 Feb 2027
See the full picture on ORTEX →Live short interest, options flow, signals, 13F filings, and more.
Key data as of 8 Nov 2026
SUPN news and analysis
RSSNo long-form analysis yet for SUPN. Pulse alerts and the live data picture are available on ORTEX.
Open SUPN on ORTEX →Want the live picture for SUPN?
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for SUPN — free to start on ORTEX.
Sign up for free →Open SUPN on ORTEX